Valentin Delahaye

- Financial strategy, Business Plan & Data consulting for start-ups

- M&A sell-side consulting : Negotiation & valuation of a biologist associate's equity shares in a French medical analysis laboratories company. Price obtained for his shares : 7M€ (+57% compared to the initial proposal)

Enovap is a customer-focused healthcare company developing unique and innovative «e-cigarette type» nicotine products to effectively help wean-off its consumers from cigarette smoking and from their nicotine addiction. CFO: Business Strategy, Finance, Administrative & Human Resources management

- Forecasting and budgeting, managing financial risk, developing financial policies and procedures

- Producing financial statements, cash flow reports and other financial analysis, managing investor relations

- Administrative & HR Management 6,5M€ in funding (3.5 in equity, 2.5 in public & private loans, 0.5 in grants), 20 employees Data Scientist, Machine Learning Engineer:

- Multiple linear regression models (i) to calibrate the vaporizer power management system to allow manual adjustment of nicotine concentration and (ii) to determine the nicotine quantity vaporized

- Recurrent Neural Network (LSTM) to predict future nicotine needs of a user (auto mode)

- Skills & Knowledges: Python, Pandas, Numpy, Scikit-learn, Tensorflow, MongoDB, RGPD, Health Data Center (OVH) 3 years of R&D, 30 k+ users, 20 M+ vape data collected Awards and distinctions:

- Laureate I-LAB 2017 by the French Minister of Innovation & Education and BPI France

- Seal of Excellence H2020 by the European commission

- Top 100 French Tech best inventors by Forbes

- Top 20/500 Mass Challenge Boston USA

European Small & Mid-market companies Within a €120M Private Debt/Equity fund :

- Financial analysis and modeling,

- Drafting of investment notes,

- Investment research,

- Portfolio analysis.